Presentation CTO 2026 Bioresorbable Scaffolds and Targeted Drug-Delivery in Chronic Total Occlusion Revascularization Presenter: Nayana Bhandari February 14, 2026
Presentation CTO 2026 Complete Staged Impella-Supported CHIP Revascularization of Dual CTOs and Critical LM–LAD Disease in Severe Ischemic Cardiomyopathy Presenter: Qasim Jehangir February 14, 2026
Presentation CTO 2026 Current Examples of Observational Studies in Coronary Revascularization – When to do a Single Arm Study and How to Analyze Large Datasets Presenter: David J. Cohen February 13, 2026
Presentation CTO 2026 Current Examples of Randomized Trials in Coronary Revascularization - Why Non-Inferiority and What is the WIN Ratio? Presenter: David J. Cohen February 13, 2026
Presentation CTO 2026 Safety and Technical Feasibility of a “Contrast-First” Strategy for Revascularization of Coronary Occlusions in Consecutive Patients Presenter: Goutham Ravipati February 13, 2026
Presentation CTO 2026 Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients Ineligible for Surgical Revascularization Presenter: Joseph Park February 13, 2026
Presentation CTO 2026 From OHCA to Complete CTO Revascularization Presenter: Nirmal J. Kaur February 13, 2026